We have constructed and cloned in bacteria recombinant plasmids containing DNA complementary to the mRNA encoding a pancreatic preproglucagon (Mr 14,500), a product of cell-free translation of angler fish islet mRNAs shown previously by immunoprecipitation analyses to be a precursor of glucagon. cDNAs of 630, 180, and 120 base pairs were isolated and correspond to most of the mRNA for the preproglucagon (650 bases). The cDNAs contain a protein coding sequence of 372 nucleotides and 5'-and 3'-untranslated regions of 58 and 206 nucleotides, respectively. From the coding sequence of the cDNAs, we find that the sequence of glucagon, identical to mammalian glucagon in 20 of29 positions, resides in the preproglucagon of 124 amino acids flanked by NH2-and COOH-peptide extensions of 52 and 43 amino acids, respectively. The peptide extensions are linked to the glucagon by Lys-Arg sequences characteristic of the sites that are cleaved during the posttranslational processing of prohormones. Notable is the finding that, following the initial Lys-Arg sequence in the COOH-peptide extension is a pentapeptide, Ser-Gly-Val-Ala-Glu, followed by another Lys-Arg and a sequence of 34 residues that shows striking homology with glucagon and the other peptides of the glucagon family-gastric inhibitory peptide, vasoactive intestinal peptide, and secretin. Thus, the preproglucagon mRNA contains two glucagon-related coding sequences arranged in tandem. The finding of Lys-Arg sequences flanking the glucagon and glucagon-related sequences suggests that these two peptides and a pentapeptide are formed in vivo by posttranslational cleavages of a common precursor.Glucagon is a 29-amino acid peptide hormone (Mr 3500) produced in the A cells of the pancreatic islets (1). The hormone belongs to a multigene family of structurally related peptides that include secretin, gastric inhibitory peptide, vasoactive intestinal peptide, and glicentin (2). These peptides variously regulate carbohydrate metabolism, gastrointestinal motility, and secretory processes (1, 3). In addition to their location in the islets and the gastrointestinal tract, substances that have glucagon-like immunoreactivity have been found in the central nervous system where they may be involved in neuroregulation (4). The principal recognized actions of pancreatic glucagon, however, are to promote glycogenolysis and gluconeogenesis, resulting in an elevation of blood sugar levels. In this regard, the actions ofglucagon are counter regulatory to those ofinsulin and may contribute to the hyperglycemia that accompanies diabetes mellitus (5).Interest has focused on studies of the biosynthesis of the glucagon-related peptides because oftheir widespread distribution in different tissues and their importance in the regulation of carbohydrate metabolism and possible functions as neuropeptides. Reports of analyses of newly labeled proteins in mammalian (6, 7), avian (8), and fish (9) islets indicate that pancreatic glucagon is synthesized in the form of a large precursor (8000-18,000...